← FDA Drug Approvals (Drugs@FDA)

CABERGOLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2013-12-02

Drug application

FDA Application #

ANDA202947

Application type

Abbreviated New Drug Application (Generic)

Brand name

CABERGOLINE

Generic name

Cabergoline

Active ingredients

CABERGOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2013-12-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown